Secondary Prevention in STEMI Patients: Insights from a Regional Virtual STEMI Clinic

STEMI 患者的二级预防:来自区域虚拟 STEMI 诊所的见解

阅读:3

Abstract

BACKGROUND: In many Canadian regions, ST-elevation myocardial infarction (STEMI) patients are managed in a "hub and spoke" model with early repatriation to referring hospitals and rapid discharge pathways that may lead to suboptimal secondary prevention during the critical postdischarge period. We implemented a regional virtual STEMI clinic (VSC) to identify and address gaps in postdischarge care. METHODS: We performed standardized virtual follow-ups for STEMI patients who presented at one tertiary hospital (hub) between November 2023 and November 2024. Standardized VSC follow-up data were used to describe baseline characteristics and secondary prevention interventions. Poisson regression was used to identify baseline characteristics associated with the likelihood of requiring secondary prevention interventions to achieve guideline-directed post-STEMI care. RESULTS: A total of 586 patients were seen in the VSC within a median of 3.9 weeks (interquartile range 2.6) post-STEMI, representing 74.6% of all STEMI patients treated at our centre. Notably, 62.2% of diabetic patients had inadequate glucose control, 19.9% of all patients had a suboptimal lipid status, and 6.6% were newly identified as prediabetic. A total of 73.1% of patients received at least one intervention, including guideline-recommended medication adjustment (35.7%), bloodwork recommendation (31.0%), and referral to cardiac rehabilitation (30.6%). Diabetes was associated with an increase in the rate of new interventions, and every 10-year increase in age was associated with a decrease. The discharging hospital was not a significant predictor of new interventions. CONCLUSIONS: A structured VSC enabled timely post-STEMI follow-up, identifying and addressing key gaps in secondary prevention postdischarge, including lifestyle modification, guideline-recommended medication optimization, and appropriate follow-up care.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。